Year |
Citation |
Score |
2015 |
Oresic Bender K, Ofori L, van der Linden WA, Mock ED, Datta GK, Chowdhury S, Li H, Segal E, Sanchez Lopez M, Ellman JA, Figdor CG, Bogyo M, Verdoes M. Design of a highly selective quenched activity-based probe and its application in dual color imaging studies of cathepsin S activity localization. Journal of the American Chemical Society. 137: 4771-7. PMID 25785540 DOI: 10.1021/Jacs.5B00315 |
0.324 |
|
2014 |
Hoskins JW, Ofori LO, Chen CZ, Kumar A, Sobczak K, Nakamori M, Southall N, Patnaik S, Marugan JJ, Zheng W, Austin CP, Disney MD, Miller BL, Thornton CA. Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects. Nucleic Acids Research. 42: 6591-602. PMID 24799433 DOI: 10.1093/Nar/Gku275 |
0.61 |
|
2014 |
Ofori LO, Hilimire TA, Bennett RP, Brown NW, Smith HC, Miller BL. High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity. Journal of Medicinal Chemistry. 57: 723-32. PMID 24387306 DOI: 10.1021/Jm401438G |
0.605 |
|
2012 |
Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL. From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy. Nucleic Acids Research. 40: 6380-90. PMID 22492623 DOI: 10.1093/Nar/Gks298 |
0.628 |
|
2010 |
Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL. Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence. Journal of Medicinal Chemistry. 53: 6018-27. PMID 20672840 DOI: 10.1021/Jm100231T |
0.464 |
|
Show low-probability matches. |